Innophos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Innophos and buy or sell other stocks, ETFs, and their options commission-free!

About IPHS

Innophos Holdings, Inc. engages in the production of specialty ingredients solutions for the food, health, nutrition, and industrial markets. Its brands include Advantra Z, Aminogen Advanced, Chelamax, INNOVALT, LEVAIR, and VOLTIX. 

CEO
Richard Hooper
CEORichard Hooper
Employees
Employees
Headquarters
Cranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded
2004
Founded2004
Employees
Employees

IPHS Key Statistics

Market cap
629.92M
Market cap629.92M
Price-Earnings ratio
29.63
Price-Earnings ratio29.63
Dividend yield
Dividend yield
Average volume
163.58K
Average volume163.58K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$37.53
52 Week high$37.53
52 Week low
$23.85
52 Week low$23.85

Stock Snapshot

As of today, Innophos(IPHS) shares are valued at $31.99. The company's market cap stands at 629.92M, with a P/E ratio of 29.63.

Innophos(IPHS) stock opened on 2026-04-21 at —. The price climbed to — and dipped to —.

The Innophos(IPHS)'s current trading volume is 0, compared to an average daily volume of 163.58K.

During the past year, Innophos(IPHS) stock moved between $23.85 at its lowest and $37.53 at its peak.

During the past year, Innophos(IPHS) stock moved between $23.85 at its lowest and $37.53 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.